[1]
Badalamenti, PharmD, V.C., Buckley, PharmD, J.W. and Smith, PharmD, E.T. 2012. Safety of EMBEDA® (morphine sulfate and naltrexone hydrochloride) extended-release capsules: Review of postmarketing adverse events during the first year. Journal of Opioid Management. 8, 2 (Mar. 2012), 115–125. DOI:https://doi.org/10.5055/jom.2012.0104.